甲狀旁腺激素聯合檢測在急性心力衰竭診斷中的價值研究
發(fā)布時間:2018-05-08 18:40
本文選題:甲狀旁腺激素 + N端B型-腦利鈉肽前體。 參考:《醫(yī)學與哲學(B)》2017年07期
【摘要】:本文選取了2016年4月~2017年2月于?谑腥嗣襻t(yī)院急診和門診首診的急性心力衰竭組100例,和健康查體中心健康組100例,分別符合納入標準進行分組比較。心力衰竭臨床診斷標準符合《2016年歐洲心臟病學會急性心力衰竭指南》。進行ELISA法檢測兩組血清PTH、NT-pro BNP,分別檢測和聯合檢測兩組的血清PTH和NT-proBNP。同時超聲心動監(jiān)測心臟血流動力學指標,再以不同左心室射血分數下分組,分別統(tǒng)計單獨檢測血清PTH和NT-proBNP和聯合檢測兩者的敏感度、特異度。結果顯示:單獨檢測血清PTH和NT-proBNP,急性心力衰竭組與健康組比較,統(tǒng)計有差異(P0.05)。分別比較兩組的聯合檢測血清PTH和NT-proBNP,急性心力衰竭組在左心室射血分數LVEF≥50%時既表現出統(tǒng)計學差異(P0.05),且敏感度和特異度高。以上說明血清PTH和NT-proBNP聯合檢測提高心衰實驗室檢查敏感性,并結合超聲血流動力學指標可提高早期未出現血流動力學障礙時急性心力衰竭診斷準確性。可有效判讀臨床結果并便于急診分級系統(tǒng)管理,尤其是社區(qū)門診監(jiān)測中射血分數尚在代償范圍的心力衰竭患者,降低心力衰竭患者的漏診和誤診。從心功能和體內電解質代謝角度及早進行多維度整體判斷心力衰竭患者病理生理變化,具有一定的臨床應用價值。
[Abstract]:From April 2016 to February 2017, 100 patients with acute heart failure and 100 healthy people in the health examination center were selected from the emergency department and outpatient clinic of Haikou people's Hospital. The patients were divided into two groups according to the inclusion criteria. The clinical diagnostic criteria for heart failure are in accordance with the European Heart Association guidelines for Acute Heart failure 2016. The serum PTH and NT-proBNPs of the two groups were detected by ELISA assay. At the same time, the cardiac hemodynamic parameters were monitored by echocardiography. The sensitivity and specificity of serum PTH and NT-proBNP were measured separately and combined with different left ventricular ejection fractions (LVEF). The results showed that serum PTH and NT-proBNPs were detected separately, and there was a statistical difference between the acute heart failure group and the healthy group (P 0.05). Serum PTH and NT-proBNPs were compared between the two groups. The acute heart failure group showed significant difference in left ventricular ejection fraction (LVEF) 鈮,
本文編號:1862567
本文鏈接:http://sikaile.net/yixuelunwen/jjyx/1862567.html
最近更新
教材專著